[
    [
        {
            "time": "2023-10-15",
            "original_text": "Danaher Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release",
            "features": {
                "keywords": [
                    "Danaher",
                    "earnings estimates",
                    "Q2 release"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "industrial"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Danaher Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "Danaher Corporation's Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?",
            "features": {
                "keywords": [
                    "Danaher Corporation",
                    "stock rallying",
                    "financials ambiguous",
                    "momentum"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "industrial"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "ambiguous"
            },
            "scores": {
                "News_content": "Danaher Corporation's Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-17",
            "original_text": "New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs",
            "features": {
                "keywords": [
                    "Rapid Molecular Test",
                    "Tuberculosis",
                    "Resistance Detection",
                    "First-Line Drugs",
                    "Second-Line Drugs"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]